177 related articles for article (PubMed ID: 35668194)
1. A single-cell map of dynamic chromatin landscapes of immune cells in renal cell carcinoma.
Kourtis N; Wang Q; Wang B; Oswald E; Adler C; Cherravuru S; Malahias E; Zhang L; Golubov J; Wei Q; Lemus S; Ni M; Ding Y; Wei Y; Atwal GS; Thurston G; Macdonald LE; Murphy AJ; Dhanik A; Sleeman MA; Tykodi SS; Skokos D
Nat Cancer; 2022 Jul; 3(7):885-898. PubMed ID: 35668194
[TBL] [Abstract][Full Text] [Related]
2. Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor-infiltrating CD8
Riegel D; Romero-Fernández E; Simon M; Adenugba AR; Singer K; Mayr R; Weber F; Kleemann M; Imbusch CD; Kreutz M; Brors B; Ugele I; Werner JM; Siska PJ; Schmidl C
Mol Cell; 2023 Feb; 83(4):622-636.e10. PubMed ID: 36657444
[TBL] [Abstract][Full Text] [Related]
3. LINC00887 Fosters Development of Clear Cell Renal Cell Carcinoma via Inhibiting CD8+ T Cell Immune Infiltration.
Wu J; Lin R; Zhang L; Wei Y; Zhang R; Cai W; Hu W
Comput Math Methods Med; 2022; 2022():2582474. PubMed ID: 36060659
[TBL] [Abstract][Full Text] [Related]
4. m
Zhong J; Liu Z; Cai C; Duan X; Deng T; Zeng G
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33574053
[TBL] [Abstract][Full Text] [Related]
5. Identification of biomarkers related to CD8
Lin J; Yu M; Xu X; Wang Y; Xing H; An J; Yang J; Tang C; Sun D; Zhu Y
Aging (Albany NY); 2020 Feb; 12(4):3694-3712. PubMed ID: 32081834
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.
Giraldo NA; Becht E; Vano Y; Petitprez F; Lacroix L; Validire P; Sanchez-Salas R; Ingels A; Oudard S; Moatti A; Buttard B; Bourass S; Germain C; Cathelineau X; Fridman WH; Sautès-Fridman C
Clin Cancer Res; 2017 Aug; 23(15):4416-4428. PubMed ID: 28213366
[No Abstract] [Full Text] [Related]
7. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
[TBL] [Abstract][Full Text] [Related]
8. Pathway signature and cellular differentiation in clear cell renal cell carcinoma.
Tun HW; Marlow LA; von Roemeling CA; Cooper SJ; Kreinest P; Wu K; Luxon BA; Sinha M; Anastasiadis PZ; Copland JA
PLoS One; 2010 May; 5(5):e10696. PubMed ID: 20502531
[TBL] [Abstract][Full Text] [Related]
9. Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway.
Ch'ng WC; Abd-Aziz N; Ong MH; Stanbridge EJ; Shafee N
Cell Oncol (Dordr); 2015 Aug; 38(4):279-88. PubMed ID: 25930675
[TBL] [Abstract][Full Text] [Related]
10. Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects.
Simon JM; Hacker KE; Singh D; Brannon AR; Parker JS; Weiser M; Ho TH; Kuan PF; Jonasch E; Furey TS; Prins JF; Lieb JD; Rathmell WK; Davis IJ
Genome Res; 2014 Feb; 24(2):241-50. PubMed ID: 24158655
[TBL] [Abstract][Full Text] [Related]
11.
Yao X; Tan J; Lim KJ; Koh J; Ooi WF; Li Z; Huang D; Xing M; Chan YS; Qu JZ; Tay ST; Wijaya G; Lam YN; Hong JH; Lee-Lim AP; Guan P; Ng MSW; He CZ; Lin JS; Nandi T; Qamra A; Xu C; Myint SS; Davies JOJ; Goh JY; Loh G; Tan BC; Rozen SG; Yu Q; Tan IBH; Cheng CWS; Li S; Chang KTE; Tan PH; Silver DL; Lezhava A; Steger G; Hughes JR; Teh BT; Tan P
Cancer Discov; 2017 Nov; 7(11):1284-1305. PubMed ID: 28893800
[TBL] [Abstract][Full Text] [Related]
12. Mapping immune cell chromatin landscapes in ccRCC.
Stone L
Nat Rev Urol; 2022 Sep; 19(9):513. PubMed ID: 35948786
[No Abstract] [Full Text] [Related]
13. Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma.
Siebenthall KT; Miller CP; Vierstra JD; Mathieu J; Tretiakova M; Reynolds A; Sandstrom R; Rynes E; Haugen E; Johnson A; Nelson J; Bates D; Diegel M; Dunn D; Frerker M; Buckley M; Kaul R; Zheng Y; Himmelfarb J; Ruohola-Baker H; Akilesh S
EBioMedicine; 2019 Mar; 41():427-442. PubMed ID: 30827930
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
[TBL] [Abstract][Full Text] [Related]
15. EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinoma.
Matušan-Ilijaš K; Damante G; Fabbro D; Dorđević G; Hadžisejdić I; Grahovac M; Avirović M; Grahovac B; Jonjić N; Lučin K
Clin Transl Oncol; 2013 Jan; 15(1):65-71. PubMed ID: 22855173
[TBL] [Abstract][Full Text] [Related]
16. Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.
Kawakami F; Sircar K; Rodriguez-Canales J; Fellman BM; Urbauer DL; Tamboli P; Tannir NM; Jonasch E; Wistuba II; Wood CG; Karam JA
Cancer; 2017 Dec; 123(24):4823-4831. PubMed ID: 28832979
[TBL] [Abstract][Full Text] [Related]
17. Alterations in chromatin accessibility and DNA methylation in clear cell renal cell carcinoma.
Buck MJ; Raaijmakers LM; Ramakrishnan S; Wang D; Valiyaparambil S; Liu S; Nowak NJ; Pili R
Oncogene; 2014 Oct; 33(41):4961-5. PubMed ID: 24186201
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral CXCL13
Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528
[TBL] [Abstract][Full Text] [Related]
19. Obesity induces limited changes to systemic and local immune profiles in treatment-naive human clear cell renal cell carcinoma.
Gibson JT; Norris KE; Wald G; Buchta Rosean CM; Thomas LJ; Boi SK; Bertrand LA; Bing M; Gordetsky JB; Deshane J; Li P; Brown JA; Nepple KG; Norian LA
PLoS One; 2020; 15(5):e0233795. PubMed ID: 32469992
[TBL] [Abstract][Full Text] [Related]
20. Seeing the forest for the trees-single-cell atlases link CD8
Koh MY; Sayegh N; Agarwal N
Cancer Cell; 2021 May; 39(5):594-596. PubMed ID: 33861995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
